Risedronate Sodium Tablet, Delayed Release
Product Images NDC 63304-440

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Risedronate Sodium (NDC 63304-440). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industires Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Fig1)

FDA Label Image

Structure 01 (Image 02)

FDA Label Image

Spl Risedronate Carton